[SaneVax: Over a year ago, Japan withdrew HPV vaccines from their national immunization schedule in response to concerns over serious adverse reactions reported by many recipients of Gardasil and Cervarix. Investigations to date have not causally linked the symptoms reported directly to either vaccine. Nevertheless, Japan’s Ministry of Health has chosen to apply the precautionary principle – they decided to continue investigations until answers are forthcoming. The real question is, “Why aren’t government health officials around the globe doing the same thing?”]
Gardasil Debate Still On One Year After It Was Taken From Japan’s Schedule
Original article from Inquisitr
It has been a year since Japan stopped actively recommending Gardasil on their national vaccine schedule after serious side effects were reported. In Japan, it has been taken off of the list of required vaccines. A causal connection between Gardasil and the serious side effects reported in Japan has not been established though, and in the U.S., the push for vaccination against HPV is stronger than ever.
“As a result of discussion at a meeting of Committee on Adverse Reactions of Immunization and Vaccine Department in the Health Science Council of the Ministry of Health, Labour and Welfare held on June 14, 2013, it is not actively recommended at present,” the chart from Japan’s IDSC explains. “However, it is available as the routine vaccination.”
“The U.S. government has taken the opposite approach amid equally alarming cases of serious side effects,” Judicial Watch stated regarding the Japanese ministry’s approach towards the Gardasil vaccine. “Not only does the Obama administration continue recommending the vaccine, it spends large sums of taxpayer dollars promoting it and works hard to keep details involving its dangers secret.”
Merck, which manufactures Gardasil, issued a statement after the Japanese decision to pull the controversial vaccine from the recommended schedule.
“While direct causal relationship between the vaccines and serious symptoms observed after inoculation has not been established at this time, we fully understand the anxiety felt by many people in Japan. In response to this decision, we will continue to collaborate with all stakeholders, including (the health ministry), to monitor and verify safety data toward resumption of active promotion for HPV vaccination as soon as possible,” a company spokesperson stated, according to Medscape.